Lipid-engineered nanotherapeutics for cancer management.

Front Pharmacol · 2023 · PMC10076603 · PMID 37033603

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an interesting trendno p-value reported

An interesting trend that was observed in the past year (2022–2023) is the increasing number of patents where a lipid-based nanoformulation is combined with DNA or RNA material, often related to immunotherapy approaches.

also in 337 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.